Foltynie Thomas, Matthews Fiona E, Ishihara Lianna, Brayne Carol
Cambridge Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK.
BMC Neurol. 2006 Aug 22;6:29. doi: 10.1186/1471-2377-6-29.
Estimates of the incidence and prevalence of chronic diseases can be made using established cohort studies but these estimates may have lower reliability if based purely on self-reported diagnosis.
The MRC Cognitive Function & Ageing Study (MRC CFAS) has collected longitudinal data from a population-based random sample of 13004 individuals over the age of 65 years from 5 centres within the UK. Participants were asked at baseline and after a two-year follow-up whether they had received a diagnosis of Parkinson's disease. Our aim was to make estimates of the incidence and prevalence of PD using self-reporting, and then investigate the validity of self-reported diagnosis using other data sources where available, namely death certification and neuropathological examination.
The self-reported prevalence of Parkinson's disease (PD) amongst these individuals increases with age from 0.7% (95%CI 0.5-0.9) for 65-75, 1.4% (95%CI 1.0-1.7) for 75-85, and 1.6% (95%CI 1.0-2.3) for 85+ age groups respectively. The overall incidence of self reported PD in this cohort was 200/100,000 per year (95%CI 144-278). Only 40% of the deceased individuals reporting prevalent PD and 35% of those reporting incident PD had diagnoses of PD recorded on their death certificates. Neuropathological examination of individuals reporting PD also showed typical PD changes in only 40%, with the remainder showing basal ganglia pathologies causing parkinsonism rather than true PD pathology.
Self-reporting of PD status may be used as a screening tool to identify patients for epidemiological study, but inevitably identifies a heterogeneous group of movement disorders patients. Within this group, age, male sex, a family history of PD and reduced cigarette smoking appear to act as independent risk factors for self-reported PD.
可以使用已有的队列研究来估计慢性病的发病率和患病率,但如果这些估计纯粹基于自我报告的诊断,其可靠性可能较低。
医学研究委员会认知功能与衰老研究(MRC CFAS)从英国5个中心的13004名65岁以上人群的基于人群的随机样本中收集了纵向数据。在基线时和两年随访后询问参与者是否被诊断为帕金森病。我们的目的是使用自我报告来估计帕金森病的发病率和患病率,然后利用其他可用数据源(即死亡证明和神经病理学检查)调查自我报告诊断的有效性。
这些个体中帕金森病(PD)的自我报告患病率随年龄增加,65 - 75岁组为0.7%(95%CI 0.5 - 0.9),75 - 85岁组为1.4%(95%CI 1.0 - 1.7),85岁及以上组为1.6%(95%CI 1.0 - 2.3)。该队列中自我报告的PD总体发病率为每年200/100,000(95%CI 144 - 278)。报告患PD的已故个体中,只有40%在其死亡证明上记录有PD诊断,报告新发PD的个体中这一比例为35%。对报告患PD的个体进行神经病理学检查也显示,只有40%有典型的PD改变,其余显示基底节病变导致帕金森综合征而非真正的PD病理。
PD状态的自我报告可作为一种筛查工具,用于识别流行病学研究的患者,但不可避免地会识别出一组异质性的运动障碍患者。在这组患者中,年龄、男性、PD家族史和吸烟减少似乎是自我报告患PD的独立危险因素。